AGC Biologics is a global CDMO providing development and manufacturing services for protein-based biologics and advanced therapies.

AGC Biologics

iFood provides food and grocery delivery services. The platform allows users to order food from various restaurants and markets.

iFood

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.

ICON Public Limited Company

Parexel is a global clinical research organization that designs and conducts clinical trials for pharmaceutical and biotechnology companies. They focus on patient-centric approaches to accelerate the development of innovative treatments, including cell and gene therapies.

Metric
Company Name	AGC Biologics	iFood	ICON Public Limited Company	Parexel
Symbol			ICLR
MSH ID	COM:AGCBIO	BR:COM:IFOOD	COM:ICONPLC	COM:PAREXEL
Market	PRIVATE	PRIVATE	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Consumer Services	Healthcare	Healthcare & Health Services
Industry	Biotechnology	Food & Beverage	Medical - Diagnostics & Research	Healthcare & Health Services
Country	US	BR	IE
Stage
Employee Count			41.15K	10.00K
Website	agcbio.com	ifood.com.br	iconplc.com	parexel.com
LinkedIn
Founders

Metric
Market Cap		27.17B
Enterprise Value
Monthly Web Traffic	17.06K		205.01K
Web Traffic Growth	0.56		0.20
Valuation
Raised Capital

Metric
Revenue			8.12B
Revenue (LTM)
Revenue (NTM)
Gross Profit			1.81B
EBITDA			1.69B
Operating Income			1.06B
Net Income			612.34M
EPS			7.46
Diluted EPS			7.40
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.28
Operating Profit Margin			0.13
EBITDA Margin			0.21
Net Profit Margin			0.09
Return on Equity			0.08
Return on Assets			0.04
Return on Capital Employed			0.08

COM:AGCBIO

AGC Biologics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			42.50
P/B Ratio			2.44
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			3.42
EV Multiple			14.63

Metric
Days Sales Outstanding			134.60
Days Payables Outstanding			5.64
Days Inventory Outstanding			0.00
Operating Cycle			133.36
Cash Conversion Cycle			126.56
Asset Turnover			0.49

Metric
Operating Cash Flow			1.16B
Free Cash Flow			1.02B
Cash Flow to Debt			0.38
Operating Cash Flow/Sales			0.16
Free Cash Flow Yield			0.02

Metric
Cash & Equivalents			378.10M
Accounts Receivable			-78.58M
Inventory
Goodwill			9.02B
Debt to Capitalization			0.29
Debt to Assets			0.24
Current Ratio			1.19
Quick Ratio			1.31

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			0.01
R&D to Revenue
SG&A to Revenue